| Identification | More | [Name]
Iopromide | [CAS]
73334-07-3 | [Synonyms]
IOPROMIDE
N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N'-methylbenzene-1,3-dicarboxamide
1,3-benzenedicarboxamide,n,n’-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino
6-triiodo-)-n-methyl-4
shl414c
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-
Ultravist
Ultravist 300
Ultravist 370
ZK 35760
N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N'-methylbenzene-1,3-dicarboxamide
N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetylamino)-N-methylisophthalamide
N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-1,3-benzenedicarboxamide
Proscope | [EINECS(EC#)]
277-385-9 | [Molecular Formula]
C18H24I3N3O8 | [MDL Number]
MFCD00867924 | [Molecular Weight]
791.11 | [MOL File]
73334-07-3.mol |
| Safety Data | Back Directory | [Hazard Codes ]
N | [Risk Statements ]
50/53 | [Safety Statements ]
60-61 | [RIDADR ]
UN 3077 9 / PGIII | [WGK Germany ]
3 | [RTECS ]
CZ2230000 | [HS Code ]
2924296000 | [Toxicity]
LD50 in mice, rats (g iodine/kg body weight): 16.5, 11.4 i.v. (Muetzel) |
| Hazard Information | Back Directory | [Description]
Iopromide is a non-ionic, water-soluble X-ray contrast agent for intravascular administration.1,2 Iopromide can cause acute kidney injury and is used in animal models of contrast-induced nephropathy.3,4 | [Chemical Properties]
White Solid | [Uses]
Contrast molecule | [Uses]
Labelled Iopromide. Nonionic, injectable radio-contrast medium. Diagnostic aid (radiopaque medium). | [Definition]
ChEBI: A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A
ater soluble x-ray contrast agent for intravascular administration. | [Brand name]
Ultravist (Berlex). | [General Description]
Iopromide is a low-osmolar,nonionic monomer with 48% bound iodine content. It is indicatedfor use in angiography, excretory urography, andnumerous CT procedures. | [Side effects]
Most common adverse reactions (>1%) are headache, nausea, injection site and infusion site reactions, vasodilatation, vomiting, back pain, urinary urgency, chest pain, pain, dysgeusia, and abnormal vision.
|
|
|